Revised (2018) COPD clinical practice guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A summary

Korean COPD

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations

Abstract

Chronic obstructive pulmonary disease (COPD) results in high morbidity and mortality among patients nationally and globally. The Korean clinical practice guideline for COPD was revised in 2018. The guideline was drafted by the members of the Korean Academy of Tuberculosis and Respiratory Diseases as well as the participating members of the Health Insurance Review and Assessment Service, Korean Physicians' Association, and Korea Respiration Trouble Association. The revised guideline encompasses a wide range of topics, including the epidemiology, diagnosis, assessment, monitoring, management, exacerbation, and comorbidities of COPD in Korea. We performed systematic reviews assisted by an expert in meta-analysis to draft a guideline on COPD management. We expect this guideline to facilitate the treatment of patients with respiratory conditions by physicians as well other health care professionals and government personnel in South Korea.

Original languageEnglish
Pages (from-to)261-273
Number of pages13
JournalTuberculosis and Respiratory Diseases
Volume81
Issue number4
DOIs
StatePublished - Oct 2018

Bibliographical note

Publisher Copyright:
Copyright © 2018 The Korean Academy of Tuberculosis and Respiratory Diseases.

Keywords

  • Chronic obstructive
  • Diagnosis
  • Guideline
  • Pulmonary disease
  • Treatment

Fingerprint

Dive into the research topics of 'Revised (2018) COPD clinical practice guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A summary'. Together they form a unique fingerprint.

Cite this